Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.
about
Clostridium difficile toxins: mechanism of action and role in disease.Clostridium difficile: its disease and toxinsProspective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrheaEnzyme-linked immunosorbent assay for Clostridium difficile toxin AWSES guidelines for management of Clostridium difficile infection in surgical patientsAntimicrobial agent-associated colitis and diarrhea.Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy.The role of anion-exchange resins in the treatment of antibiotic-associated pseudomembranous colitis.An agent-based simulation model for Clostridium difficile infection controlTreatment of Clostridium difficile-associated disease with teicoplanin.Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy.Cost-Effectiveness Analysis of Six Strategies to Treat Recurrent Clostridium difficile Infection.MAPK-activated protein kinase 2 contributes to Clostridium difficile-associated inflammationClostridium difficile colitis following treatment with metronidazole and vancomycin.Effects of Clostridium difficile toxins given intragastrically to animals.Structural Insights into Substrate Recognition by Clostridium difficile Sortase.Variations in virulence and molecular biology among emerging strains of Clostridium difficile.Household pets as a potential reservoir for Clostridium difficile infection.Isolation of Clostridium difficile from patients and the environment of hospital wards.Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent clostridium difficile-associated diarrhea.Suppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamsters.Analysis of the in vitro interaction between vancomycin and cholestyramineClostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions.Rapid detection of Clostridium difficile toxin in human feces.Fatal pseudomembranous colitis despite eradication of Clostridium difficile
P2860
Q24522454-15DDD723-3239-4210-BFA6-61B23A7139DEQ24617347-AE016FBB-315B-4AED-A9BD-BCBD20D83CDAQ24644390-98BAB1A8-13C7-4496-9CD3-BB4EE8F6A24FQ24652980-50D4621F-DA65-43A5-9ED8-411AF34D7F46Q26795429-9AD6E6C2-BCB9-467C-8A97-D9EF1E145036Q34108598-178F15BC-7231-48A0-A4D8-5EA3BD6E7149Q34495739-F11AD389-E958-42C5-9EC4-76A59A67A0B6Q34631838-D5AA0AF9-89C5-458D-A649-97D1E32F3E36Q35031203-9E29017D-666D-45AA-A0AD-840576DA666DQ35566657-95D7D39B-8ABD-46F9-9324-BD1A51261EA4Q35596453-15A08227-BBAD-4D65-997F-96E5AE89F898Q35930922-AA7E54FD-6D6F-45DE-8292-70533B4A8E28Q36646782-7091A4A9-1960-4535-95C8-FC508FE24631Q36722103-E1D5050A-5BB1-46CB-9FE7-E09D87A782D7Q37074797-10189CF0-E418-4C6D-A6C5-CC5DFF708E44Q37427548-0AF4C7A9-3A77-43E0-BF76-9757537F98D3Q37680481-CC16D1D2-E610-4778-BF0D-940249DC2D1AQ39504018-4930A8B8-D9E2-4157-AB97-AE9BFE62950DQ39504064-8526590F-E96F-4C09-AAF7-CB93912E21B9Q39789836-C39B6A92-1A64-48F4-B8B7-4E3DF0029E4DQ39827540-A67A7D34-23A4-43AC-B7CC-E92CAC3F96E4Q39854592-6038EC7C-586B-4DA9-B027-D268F219EA45Q40224029-75ECB2CD-25DF-46B8-8346-128AAD7E2202Q40231483-A8FC7955-4712-4F15-B6FE-2289D3CDFE70Q41698855-67F56B4F-E903-4D7F-8FFC-BED83D624734
P2860
Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
Symptomatic relapse after oral ...... ated pseudomembranous colitis.
@en
type
label
Symptomatic relapse after oral ...... ated pseudomembranous colitis.
@en
prefLabel
Symptomatic relapse after oral ...... ated pseudomembranous colitis.
@en
P2093
P1433
P1476
Symptomatic relapse after oral ...... ated pseudomembranous colitis.
@en
P2093
P304
P407
P577
1980-03-01T00:00:00Z